Skip to content

Clinical trials

Completed Phase 2/3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Phase: Phase 2/3 Status: Completed Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20061
20071
20091
20141

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amneal Pharmaceuticals, LLC1
Ann & Robert H Lurie Children's Hospital of Chicago1
Gamida Cell -Teva Joint Venture Ltd.1
Gruppo Italiano Trapianto di Midollo Osseo1
Hoffmann-La Roche1
Novartis Pharmaceuticals1
St. Anna Kinderkrebsforschung1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive7
Leukemia, Myeloid, Acute3
Precursor Cell Lymphoblastic Leukemia-Lymphoma3
Anemia, Refractory, with Excess of Blasts1
Carcinoma, Renal Cell1
Gastrointestinal Stromal Tumors1
Hematologic Neoplasms1
Hodgkin Disease1
Leukemia1
Leukemia, Lymphoid1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.